SCHEMBL7014390

SCHEMBL7014390

N#CC1(N(Cc2ccccc2)C(=O)C(C(N)=O)C2CCCCC2)CNC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
EPHX1 P07099 4/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATM Q13315 2/20 0.34
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
EPHX2 P34913 1/20 0.33
METAP2 P50579 2/20 0.32
TP53 P04637 1/20 0.32
AGER Q15109 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6371524 0.92 L3MBTL1 (0.40) L3MBTL1MEN1KMT2AEPHX1ALDH1A1
SCHEMBL7420833 0.90 L3MBTL1 (0.41) L3MBTL1MEN1KMT2AEPHX1ALDH1A1
SCHEMBL7417235 0.72 L3MBTL1 (0.35) L3MBTL1MEN1KMT2AEPHX1ALDH1A1
SCHEMBL7014387 0.71 SNCA (0.33) ALDH1A1
SCHEMBL7419141 0.70 AGER (0.39) HTTNPSR1AGER
SCHEMBL7415546 0.69 PSEN1 (0.34) ALDH1A1KDM4EAGER
SCHEMBL7417228 0.68 CTSL (0.44) ATM
SCHEMBL7422438 0.68 PKM (0.42) MEN1KMT2AALDH1A1
SCHEMBL7014601 0.66 EPHX1 (0.50) EPHX1
SCHEMBL7021618 0.65 SNCA (0.34) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003529546-A 2003-10-07 JP claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP claimed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed